Literature DB >> 14463753

Mechanism of the antagonism by pralidoxime and 1,1-trimethylenebis(4-hydroxyiminomethylpyridinium) of the action of echothiphate on the intestine.

R A LEHMAN.   

Abstract

Pralidoxime chloride (pyridine-2-aldoxime methochloride; Protopam Chloride) and 1,1'-trimethylenebis(4-hydroxyiminomethylpyridinium bromide) (TMB-4) antagonize the spasm of the isolated or intact small intestine of the rabbit caused by the anticholinesterase, echothiophate iodide (S-2-dimethylaminoethyl OO-diethyl phosphorothiolate methiodide; Phospholine Iodide). In vitro, both oximes also antagonize the spasm caused by acetylcholine. The quantitative relationships have been studied in comparison with the activity of atropine against echothiophate and acetylcholine. Echothiophate-treated intestine which is subjected to a concentration of oxime sufficient to cause 100% restoration of function (but not cholinesterase reactivation) will go back into spasm on washing out both drugs. Strips treated with a high concentration of oxime, sufficient to cause 100% reactivation of cholinesterase, exhibit normal control tone and motility after washing. It is concluded that pralidoxime and 1,1'-trimethylenebis(4-hydroxyiminomethylpyridinium bromide) have an anticholinergic action as well as the ability to reactivate cholinesterase and that this action plays a significant part in the initial recovery of function under the conditions of these experiments.

Entities:  

Keywords:  CHOLINESTERASE/antagonists; HYDROXYLAMINES/pharmacology; INTESTINE, SMALL/pharmacology; PARASYMPATHOLYTICS/pharmacology; PYRIDINES/pharmacology

Mesh:

Substances:

Year:  1962        PMID: 14463753      PMCID: PMC1482115          DOI: 10.1111/j.1476-5381.1962.tb01408.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  15 in total

1.  Comparison of the effects of inhibition of external, internal and total acetylcholinesterase upon ganglionic transmission.

Authors:  R J McISAAC; G B KOELLE
Journal:  J Pharmacol Exp Ther       Date:  1959-05       Impact factor: 4.030

2.  Oxime mixtures and atropine in the protection of mice and rats from sarin poisoning.

Authors:  I W COLEMAN; P E LITTLE; G A GRANT
Journal:  Can J Biochem Physiol       Date:  1960-10

3.  Antidotes and potentiating agents for phospholine iodide.

Authors:  R A LEHMAN; H M FITCH; L P BLOCHI; H A JEWELL; M E NICHOLLS
Journal:  J Pharmacol Exp Ther       Date:  1960-03       Impact factor: 4.030

4.  Use of a thiophosphinyl quaternary compound (217-MI) in treatment of glaucoma.

Authors:  I H LEOPOLD; P GOLD; D GOLD
Journal:  AMA Arch Ophthalmol       Date:  1957-09

5.  [Specific antidote treatment in protracted poisoning with alkylphosphates (paraoxon, parathion, DFP) & eserin in guinea pigs].

Authors:  K BETHE; W D ERDMANN; L LENDLE; G SCHMIDT
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1957

6.  Toxicity of diacetyl monoxime and of pyridine-2-aldoxime methiodide in man.

Authors:  B V JAGER; G N STAGG
Journal:  Bull Johns Hopkins Hosp       Date:  1958-04

7.  A specific antidote against lethal alkyl phosphate intoxication. II. Antidotal properties.

Authors:  H KEWITZ; D NACHMANSOHN; I B WILSON
Journal:  Arch Biochem Biophys       Date:  1956-10       Impact factor: 4.013

8.  A powerful reactivator of alkylphosphate-inhibited acetylcholinesterase.

Authors:  I B WILSON; B GINSBURG
Journal:  Biochim Biophys Acta       Date:  1955-09

9.  The cerebral distributions of a tertiary and a quaternary anticholinesterase agent following intravenous and intraventricular injection.

Authors:  G B KOELLE; E C STEINER
Journal:  J Pharmacol Exp Ther       Date:  1956-12       Impact factor: 4.030

10.  Antagonism of phospholine (echothiophate) iodide by certain quaternary oximes.

Authors:  R A LEHMAN; M E NICHOLLS
Journal:  Proc Soc Exp Biol Med       Date:  1960 Aug-Sep
View more
  1 in total

1.  A central vasodepressor effect of Dyflos.

Authors:  H Edery; P G Guertzenstein
Journal:  Br J Pharmacol       Date:  1974-04       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.